Finally, the treatment of GnRH-R-positive xenografted mice with GSG showed a significant advantage in tumor growth inhibition when compared with the control group (vehicle) or the equimolar doses of gemcitabine or [D-Lys6]-GnRH. The gene discussed is GNRH1; the disease is neoplasm.